1. Home
  2. LCFY vs DOMH Comparison

LCFY vs DOMH Comparison

Compare LCFY & DOMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LCFY
  • DOMH
  • Stock Information
  • Founded
  • LCFY 2009
  • DOMH 1967
  • Country
  • LCFY Australia
  • DOMH United States
  • Employees
  • LCFY N/A
  • DOMH N/A
  • Industry
  • LCFY
  • DOMH Biotechnology: Pharmaceutical Preparations
  • Sector
  • LCFY
  • DOMH Health Care
  • Exchange
  • LCFY Nasdaq
  • DOMH Nasdaq
  • Market Cap
  • LCFY 7.3M
  • DOMH 8.8M
  • IPO Year
  • LCFY 2022
  • DOMH N/A
  • Fundamental
  • Price
  • LCFY $7.42
  • DOMH $3.02
  • Analyst Decision
  • LCFY
  • DOMH
  • Analyst Count
  • LCFY 0
  • DOMH 0
  • Target Price
  • LCFY N/A
  • DOMH N/A
  • AVG Volume (30 Days)
  • LCFY 24.4K
  • DOMH 427.5K
  • Earning Date
  • LCFY 04-01-2025
  • DOMH 03-31-2025
  • Dividend Yield
  • LCFY N/A
  • DOMH N/A
  • EPS Growth
  • LCFY N/A
  • DOMH N/A
  • EPS
  • LCFY N/A
  • DOMH N/A
  • Revenue
  • LCFY $2,668,385.00
  • DOMH $12,589,000.00
  • Revenue This Year
  • LCFY N/A
  • DOMH N/A
  • Revenue Next Year
  • LCFY N/A
  • DOMH N/A
  • P/E Ratio
  • LCFY N/A
  • DOMH N/A
  • Revenue Growth
  • LCFY N/A
  • DOMH 1117.50
  • 52 Week Low
  • LCFY $2.20
  • DOMH $0.83
  • 52 Week High
  • LCFY $11.23
  • DOMH $4.35
  • Technical
  • Relative Strength Index (RSI)
  • LCFY 43.49
  • DOMH 65.22
  • Support Level
  • LCFY $7.10
  • DOMH $2.86
  • Resistance Level
  • LCFY $9.39
  • DOMH $4.35
  • Average True Range (ATR)
  • LCFY 0.64
  • DOMH 0.52
  • MACD
  • LCFY -0.15
  • DOMH 0.14
  • Stochastic Oscillator
  • LCFY 8.16
  • DOMH 53.19

About LCFY Locafy Limited

Locafy Ltd is focused on commercializing its Software as a Service (SaaS) online publishing technology platform. Its platform enables the ability to publish almost any type of content to almost any device that uses a web browser to display web content. The firm has three operating segments: the Publishing segment, the Reseller segment, and the Channel sales segment. It derives a majority of its revenue from Australia and New Zealand.

About DOMH Dominari Holdings Inc.

Dominari Holdings Inc is a biotechnology company with a diverse portfolio of small-molecule anticancer and antiviral therapeutics in development. The company's oncology therapeutics include treatments for pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia.

Share on Social Networks: